ArticleNature communications2025
Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy.
Xiaolu Ge et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature communications2025
Xiaolu Ge et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.